Filter News
Area of Research
- (-) Fusion and Fission (3)
- (-) Isotopes (3)
- Biological Systems (1)
- Biology and Environment (40)
- Clean Energy (12)
- Computational Biology (1)
- Materials (15)
- Materials for Computing (1)
- National Security (3)
- Neutron Science (7)
- Nuclear Science and Technology (1)
- Quantum information Science (1)
- Supercomputing (25)
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (3)
- (-) Frontier (1)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (2)
- Artificial Intelligence (1)
- Buildings (1)
- Chemical Sciences (2)
- Composites (1)
- Computer Science (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (2)
- Exascale Computing (1)
- Fusion (12)
- Grid (1)
- High-Performance Computing (2)
- Isotopes (15)
- ITER (2)
- Materials (2)
- Materials Science (1)
- National Security (1)
- Net Zero (1)
- Nuclear Energy (19)
- Partnerships (1)
- Security (1)
- Simulation (2)
- Space Exploration (2)
- Sustainable Energy (3)
- Transportation (1)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — Oak Ridge National Laboratory was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.
As renewable sources of energy such as wind and sun power are being increasingly added to the country’s electrical grid, old-fashioned nuclear energy is also being primed for a resurgence.
Oak Ridge National Laboratory physicist Elizabeth “Libby” Johnson (1921-1996), one of the world’s first nuclear reactor operators, standardized the field of criticality safety with peers from ORNL and Los Alamos National Laboratory.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.